TP53 and neoplasm: Early studies of benzo[α]pyrene-induced fibrosarcomas in MIF-KO mice exhibited enhanced p53 activity in vitro and reduced tumor growth in vivo, suggesting MIF drives development of cutaneous fibrosarcomas via p53 suppression [125].